Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Eric Tarride

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 9, 2020
Methodological approaches to the design and analysis of nonrandomized intervention studies for the prevention of child and adolescent obesityRavinder Sandhu, Lawrence Mbuagbaw, Jean-Eric Tarride, et al.
MDM Policy & Practice|October 6, 2018
Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized DataJason R Guertin, James M Bowen, Guy De Rose, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 12, 2009
Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational studyFeng Xie, Ngai-Nung Lo, Jean-Eric Tarride, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
General population versus disease-specific event rate and cost estimates: potential bias for economic appraisalsRon Goeree, Daria O'Reilly, Robert Hopkins, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2010
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?Eleanor M Pullenayegum, Jean-Eric Tarride, Feng Xie, et al.
Annals of Internal Medicine|August 18, 2020
Association Between Bariatric Surgery and All-Cause Mortality: A Population-Based Matched Cohort Study in a Universal Health Care SystemAristithes G Doumouras, Dennis Hong, Yung Lee, et al.
CJC Open|January 21, 2021
One-Year Costs Associated with Hospitalizations Due to Aortic Stenosis in CanadaJean-Eric Tarride, Sandra Lauck, Madhu K Natarajan, et al.
The Journal of Infectious Diseases|December 15, 2022
Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US InfantsJohn Fullarton, Ian Keary, Bosco Paes, et al.
Tobacco Control|August 11, 2021
Return on investment of Canadian tobacco control policies implemented between 2001 and 2016Jean-Eric Tarride, Gord Blackhouse, G Emmanuel Guindon, et al.
Bone|September 8, 2023
Prevalence and incidence of Paget's disease of bone: Temporal trend over 20 years in the province of Quebec, CanadaLaetitia Michou, Philippe Gamache, Jason R Guertin, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 9, 2020
Methodological approaches to the design and analysis of nonrandomized intervention studies for the prevention of child and adolescent obesityRavinder Sandhu, Lawrence Mbuagbaw, Jean-Eric Tarride, et al.
MDM Policy & Practice|October 6, 2018
Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized DataJason R Guertin, James M Bowen, Guy De Rose, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 12, 2009
Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational studyFeng Xie, Ngai-Nung Lo, Jean-Eric Tarride, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
General population versus disease-specific event rate and cost estimates: potential bias for economic appraisalsRon Goeree, Daria O'Reilly, Robert Hopkins, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2010
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?Eleanor M Pullenayegum, Jean-Eric Tarride, Feng Xie, et al.
Annals of Internal Medicine|August 18, 2020
Association Between Bariatric Surgery and All-Cause Mortality: A Population-Based Matched Cohort Study in a Universal Health Care SystemAristithes G Doumouras, Dennis Hong, Yung Lee, et al.
CJC Open|January 21, 2021
One-Year Costs Associated with Hospitalizations Due to Aortic Stenosis in CanadaJean-Eric Tarride, Sandra Lauck, Madhu K Natarajan, et al.
The Journal of Infectious Diseases|December 15, 2022
Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US InfantsJohn Fullarton, Ian Keary, Bosco Paes, et al.
Tobacco Control|August 11, 2021
Return on investment of Canadian tobacco control policies implemented between 2001 and 2016Jean-Eric Tarride, Gord Blackhouse, G Emmanuel Guindon, et al.
Bone|September 8, 2023
Prevalence and incidence of Paget's disease of bone: Temporal trend over 20 years in the province of Quebec, CanadaLaetitia Michou, Philippe Gamache, Jason R Guertin, et al.
Pageof 22